ANAXIS PHARMA

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ANAXIS PHARMA was filed as Word mark on 09/10/2021 at the World Intellectual Property Organization.

Trademark Details Last update: July 26, 2023

Trademark form Word mark
File reference 1624543
Countries European Community United Kingdom United States of America (USA)
Base trademark AU No. 2207985, September 3, 2021
Application date September 10, 2021
Expiration date September 10, 2031

Trademark owner

1G Royal Parade
Parkville VIC 3052
AU

Trademark representatives

Level 24, 80 Collins Street Melbourne VIC 3000 AU

goods and services

42 Scientific research and development; pharmaceutical research and development; pharmaceutical research advisory and pharmaceutical testing services; preparation of scientific reports; scientific research, design, analysis and testing of pharmaceutical products; conducting medical research and clinical trials; provision of scientific information; scientific and technical analysis; scientific consultancy; scientific research in the field of pharmacy; medical research; research and development of products; research relating to pharmaceuticals; advisory and consultancy services relating to the aforementioned services
45 Licensing of intellectual property rights; legal services relating to the exploitation of intellectual property rights; enforcement of intellectual property rights; advisory services relating to intellectual property rights; research relating to intellectual property

Trademark history

Date Document number Area Entry
July 21, 2023 2023/30 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 30, 2022 2022/26 Gaz US Rejection
March 23, 2022 2022/12 Gaz EM Rejection
February 17, 2022 2022/7 Gaz GB Rejection
September 10, 2021 2021/42 Gaz AU Registration

ID: 141624543